This fungal fraction shows significant inhibitory activity against Streptococcus pneumoniae, a pathogenic bacterium responsible for various respiratory infections. Additionally, moderate activity against Streptococcus agalactiae and Cryptococcus neoformans has been observed. These findings suggest therapeutic potential in addressing infections caused by these bacterial and fungal species.
HB3Y1H represents hope in addressing the urgent need for new effective antibiotics against Cryptococcus neoformans, Streptococcus agalactiae, and Streptococcus pneumoniae, offering a promising perspective in the fight against these infections.
Know more about the pathogens